On November 1, 2019, Maged Shenouda submitted formal notice of his resignation as Chief Financial Officer of AzurRx BioPharma, Inc. Mr. Shenouda's resignation was not due to any disagreements with respect to the Company's operations, policies or practices. The Company is actively engaged in finding a successor to fill the vacancy created by Mr. Shenouda's resignation. Mr. Shenouda has agreed to remain in his position to fulfill his role as principal accounting and financial officer through November 30, 2019 to assist in the transition of his duties to a new Chief Financial Officer.